Tianjin Ringpu Bio Tech Cash Flow Conversion Efficiency

Latest as of September 2025: 0.020x

Tianjin Ringpu Bio Tech cash flow conversion efficiency. Based on the latest financial reports, Tianjin Ringpu Bio Tech (300119) has a cash flow conversion efficiency ratio of 0.020x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥105.02 Million ≈ $15.37 Million USD) by net assets (CN¥5.15 Billion ≈ $753.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Tianjin Ringpu Bio Tech (2007–2025)

Cash flow conversion efficiency of Tianjin Ringpu Bio Tech from 2007 to 2025. This chart illustrates how Tianjin Ringpu Bio Tech's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Tianjin Ringpu Bio Tech (300119) share price today for real-time trading data and today's change.

Tianjin Ringpu Bio Tech Cash Flow Conversion Ratio Explained

Tianjin Ringpu Bio Tech cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Tianjin Ringpu Bio Tech Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tianjin Ringpu Bio Tech ranked by their cash flow conversion efficiency. Also see 300119 market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Flow Traders BV AS:FLOW	-1.463x
TTW Public Company Limited BK:TTW-R	0.043x
Hunan Boyun New Materials Co Ltd SHE:002297	0.037x
Qingdao Yunlu Advanced Materials Technology Co. Ltd. A SHG:688190	N/A
JiLin Sino-Microelectronics Co Ltd SHG:600360	0.476x
Goldsun Building Materials Co Ltd TW:2504	0.019x
NationGate Holdings Berhad KLSE:0270	0.091x
Lotte Corp KO:004990	0.052x

Annual Cash Flow Conversion Efficiency for Tianjin Ringpu Bio Tech (2007–2025)

The table below shows the annual cash flow conversion efficiency of Tianjin Ringpu Bio Tech from 2007 to 2025. Review 300119 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥5.18 Billion ≈ $758.67 Million	CN¥297.53 Million ≈ $43.54 Million	0.057x	-60.94%
2024-12-31	CN¥5.01 Billion ≈ $732.68 Million	CN¥735.55 Million ≈ $107.63 Million	0.147x	+86.64%
2023-12-31	CN¥4.80 Billion ≈ $703.11 Million	CN¥378.20 Million ≈ $55.34 Million	0.079x	-9.04%
2022-12-31	CN¥4.50 Billion ≈ $658.65 Million	CN¥389.49 Million ≈ $56.99 Million	0.087x	-2.22%
2021-12-31	CN¥4.32 Billion ≈ $632.69 Million	CN¥382.63 Million ≈ $55.99 Million	0.088x	-37.64%
2020-12-31	CN¥2.74 Billion ≈ $400.51 Million	CN¥388.44 Million ≈ $56.84 Million	0.142x	-12.80%
2019-12-31	CN¥2.36 Billion ≈ $344.92 Million	CN¥383.61 Million ≈ $56.13 Million	0.163x	+109.80%
2018-12-31	CN¥2.25 Billion ≈ $329.89 Million	CN¥174.88 Million ≈ $25.59 Million	0.078x	+56.93%
2017-12-31	CN¥2.18 Billion ≈ $318.46 Million	CN¥107.57 Million ≈ $15.74 Million	0.049x	-49.89%
2016-12-31	CN¥2.11 Billion ≈ $308.09 Million	CN¥207.67 Million ≈ $30.39 Million	0.099x	-22.55%
2015-12-31	CN¥1.77 Billion ≈ $258.84 Million	CN¥225.27 Million ≈ $32.96 Million	0.127x	+71.20%
2014-12-31	CN¥1.73 Billion ≈ $252.53 Million	CN¥128.37 Million ≈ $18.78 Million	0.074x	+44.29%
2013-12-31	CN¥1.72 Billion ≈ $251.73 Million	CN¥88.68 Million ≈ $12.98 Million	0.052x	-9.05%
2012-12-31	CN¥1.59 Billion ≈ $232.13 Million	CN¥89.92 Million ≈ $13.16 Million	0.057x	-6.07%
2011-12-31	CN¥1.50 Billion ≈ $218.92 Million	CN¥90.29 Million ≈ $13.21 Million	0.060x	-23.68%
2010-12-31	CN¥1.43 Billion ≈ $208.78 Million	CN¥112.82 Million ≈ $16.51 Million	0.079x	-69.09%
2009-12-31	CN¥252.48 Million ≈ $36.95 Million	CN¥64.59 Million ≈ $9.45 Million	0.256x	-6.06%
2008-12-31	CN¥249.97 Million ≈ $36.58 Million	CN¥68.07 Million ≈ $9.96 Million	0.272x	+93.74%
2007-12-31	CN¥136.21 Million ≈ $19.93 Million	CN¥19.15 Million ≈ $2.80 Million	0.141x	--

About Tianjin Ringpu Bio Tech

SHE:300119 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.15 Billion

CN¥7.86 Billion CNY

Market Cap Rank

#8021 Global

#1755 in China

Share Price

CN¥16.91

Change (1 day)

+0.65%

52-Week Range

CN¥14.38 - CN¥21.44

All Time High

CN¥39.94